Drug recall · July 4, 2012
Zeosa (norethindrone and ethinyl estradiol tablets USP recall
Why: Impurities/Degradation: This recall is being carried out due to the potential for some lots not meeting impurity specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP, (chewable) 75 mg), 3 Blister Cards, 28 Tablets Each, Rx only, TEVA Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-2090-28 and 0093-2090-58, cartons containing three (3) individual blister packs
- Lots / codes
Lot #'s 33800226A, Exp 7/2012; 33800333A, Exp 10/2012; 33800870A, Exp 10/2012; 33802533A, Exp 4/2013; and 33802720A, Exp 8/2013
- Quantity
- 100,761 cartons
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide
- Initiated
- May 2, 2012 · Voluntary: Firm initiated
- Classified
- June 26, 2012
- Reported
- July 4, 2012
- Ended
- April 10, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.